They’ve been heralded as the magic drugs that treat obesity when diet and exercise have failed. But Ozempic and Wegovy – and ...

Britons paying privately for obesity drugs are increasingly choosing Eli Lilly's Mounjaro over Novo Nordisk's Wegovy, online pharmacies say, in a sign the U.S. drugmaker is gaining ground on its ...

Despite an estimated 3.4 million people in England meeting the eligibility criteria for Mounjaro, fewer than 10% will ...

The decision to limit Mounjaro injections to 220,000 people is ‘short-sighted and absurd’, says the former prime minister’s ...

A man who ‘thought he was going to die’ after using the ‘King Kong’ of weight loss injections is warning others of the ...

Eli Lilly's weight-loss jab Mounjaro has been cleared for rollout by the NHS in England, with around 3.4 million people eligible, but will be made available in stages to limit the financial impact.

STORY: The battle of the weight loss drugs continues, as Britons paying privately for obesity drugs are increasingly choosing ...

With obesity rates skyrocketing in the UK, the a 28-year-old social media specialist expressed support for the wider ...

He's warning others of the potential dangers - despite shedding three-and-a-half stone. Georgie Aldous, from Great Yarmouth ...

智通财经APP获悉，网上药店数据显示，英国私人购买减肥药的人数持续增长，其中礼来公司(LLY.US)的Mounjaro正逐渐超越诺和诺德公司(NVO.US)的Wegovy，成为消费者的新宠。这一现象标志着美国制药商礼来在欧洲市场竞争中逐渐逼近其对手诺 ...

礼来公司的Mounjaro于今年2月在英国上市，是其在美国以外的首批市场之一，也是与诺和诺德直接竞争的少数几个国家之一。与此同时，分析师估计未来十年全球减肥药市场规模可能高达每年1500亿美元，而英国作为人口较多的欧洲市场之一，对这两种药物的上市具有 ...

Weight-loss injection Mounjaro, also known as tirzepatide, will be rolled out on the NHS gradually over a 12-year period.